BOSTON and PARIS, July 25, 2019 /PRNewswire/ -- PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage bioelectronic medicine company developing breakthrough non-invasive

BOSTON, July 25, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced that the first patient has been dosed in the Company's 28-day, Phase 2 study evaluating its proprietary cystic fibrosis transme

DUBLIN, July 25, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the second quarter of 2019. "Our second quarter results reflect the grow

CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will host a conference call on August 6, 2019, to provide a program update for DKN-01, a humanized monoclonal antibody targeting the Dickk

BRUSSELS, July 25, 2019 /PRNewswire/ --– Regulated information – Revenue reached € 2.3 billion (+2%, +4% CER1) net sales increased to € 2.2 billion (+3%, +5% CER – adjusted2 +11%, +7% CER) Underlying profitability (rEBITDA3) was € 724 million (-9%, -1%

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries, announced today their partner

LEEDS, England, July 25, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its oncology programmes. New preclinical data on the Company's oncology candidates, MRx0518 and MRx1299, were presented at 1st Microbiome Movement Oncology Response Summit in

BIRMINGHAM, Ala., July 25, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a 50-bed, freestanding inpatient rehabilitation hospital in Tampa Bay, Florida.

SAN DIEGO, July 25, 2019 /PRNewswire/ -- Snap Bio, Inc. and Torrey Pines Investment (TPI) announced today that their joint early drug discovery program within the framework of the i2020 Accelerator has resulted in achieving the projected milestone in developing several small molecule lead candidates for treatment of Hepatocellular carcinoma (HCC) and Hepatoblastoma. The

EXTON, Pa., July 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.